Skip to content

GenomeDx is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers.

Home
About
- Mission
- Our Story
- Video Library
- Our Team
- Careers
Pharmacy
Science
Products
- Priligy (Dapoxetine)
- Generic Viagra (Sildenafil)
Media
- Press Releases
Contact Us

Media

Keep up with the latest from GenomeDx Biosciences using the links below.

Press Releases

Search

Press Releases

New Study Shows that Genetic Information from Prostate Needle Biopsy May Be Used to Predict Tumor Aggressiveness – GenomeDx
New Study Demonstrates that GenomeDx’s Decipher™ Test was Superior to Current Risk Assessment Tools in Predicting Metastatic Prostate Cancer
GenomeDx’s Decipher GRID and Decipher Biopsy to be Featured at the 31st Annual EAU Congress

Contact Us

Client Service
1.888.792.1601
client.service@genomedx.com

General Inquiries
info@genomedx.com

For Business Development & Collaboration Inquiries
partner@genomedx.com

About GenomeDx

Mission
Our Story
Team
Careers

Copyright © 2023 GenomeDx. All Rights Reserved.